Currently being used in five European clinical studies, Nia Health is a digital medical platform geared towards those suffering from chronic skin conditions such as neurodermatitis. Through digital therapeutics and consultations, Nia also aids in the monitoring of patients and treatments through industry data analysis, which can be leveraged by businesses as well as patients.
This multi-pronged solution to chronic skin conditions has drawn major investment from Biomed investors such as Ventura and the Berlin University of Medicine. In response, Nia has been scaling up its operations throughout the EU.
The investment will be used to lay the groundwork for US market entry, something that it is primed for after partnering with the likes of Sanofi and Pfizer since its founding in 2019. With revenue doubling between 2021 and 2022, Nia is on the right path for continued growth.
Steph
Company Specialist at Welcome to the Jungle